Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Back to the letter...

Besides like I've said 50/60M shares sounds good but little over 11% is not that meaningful when you consider 500M shares outstanding.

So ... the impact that Swartz has had while holding a comparable number of shares is also "not that meaningful"? IMO, shareholders representing 11% of shares outstanding can have a considerable impact.

Share
New Message
Please login to post a reply